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Dear Editor, 
 
 Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are acute 
severe skin reactions with extensive apoptosis of the epidermis and mucous membranes.1 
Ocular involvement occurs in up to 75% of patients at the acute phase, described as mild, 
moderate and severe involvement and may result in long-term severe sequelae with 
dryness, photophobia, cicatrising conjunctivitis complicated with corneal vascularisation and 
scarring, which may result in severe visual loss.2,3 The acute management of SJS/TEN ocular 
complications has not been codified. The place of amniotic membrane transplantation 
remains to be specified, especially for patients with the most severe complications.4 
Ophthalmological rehabilitation strategy may include the use of scleral lenses, which 
significantly improve visual acuity and quality of life in SJS/TEN patients.5 
 As previously described, the prevalence of long-term visual disability increases with 
the initial ocular severity, 2,6 but other risk factors have been poorly described. Considering 
the abnormal wound-healing process in dark phototypes (Fitzpatrick phototype scale V-VI), 
we hypothesized that the same pathological profibrotic process could involve the ocular 
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surface. The aim of the study was to evaluate if SJS/TEN patients with dark phototypes (V-
VI) had more severe ocular sequelae than light phototypes (I to IV). 
 We retrospectively included SJS/TEN patients with late ocular complications referred 
to the specific scleral contact lens consultation of the Ophthalmology Departments of Rouen 
and Bichat-Claude Bernard University Hospitals, France, from 2003 to 2016. Patient 
phototypes were determined from eyelid pigmentation on slit lamp photographies by 
dermatologist-trained ophthalmologists. Exclusion criteria were lack of data (i.e. absence of 
photograph and/or detailed ophthalmological results) or non-discriminatory phototype slit 
lamp photographies. Clinical and ophthalmological data from patient charts were described 
according to their skin phototype (I to IV versus V-VI). With regard to ophthalmological 
complications, we specifically detailed the severity of visual acuity loss defined by a visual 
acuity without scleral lens of ≤20/200 in the worst eye and the presence of other severe 
sequelae, i.e severe cicatrising conjunctivitis (symblepharons, trichiasis/distichiasis), corneal 
punctate epithelial erosions, corneal vascularisation and corneal ulceration (Fig.1).  
 The study was approved by the local Institutional Review Board (E2018-62). 
 
Among 90 patients examined during the study period, 21 were excluded and 69 (41 
female) were included. Median age was 45 years (range, 17 - 79). There was no difference in 
patients’ characteristics regarding age and sex. Forty-six patients had phototypes I-IV (67%) 
and 23 patients had phototypes V-VI (33%). The median duration between the acute phase 
and the specialised contact lens consultation was 6 years (range, 6 months to 44 years). A 
visual acuity of ≤20/200 in the worst eye was significantly more frequent in phototypes V-VI 
(18/23; 78%) than in phototypes I-IV (23/46; 50%, chi-squared test, p=0.037). 
Symblepharons and trichiasis/distichiasis were significantly more frequent in phototypes V-
VI (13/23; 56% vs 10/46; 22%, chi-squared test, p=0.006). Corneal ulceration was also more 
frequent in phototypes V-VI (16/23; 48% vs 25/46; 24%, chi-squared test, p=0.05). However, 
there was no significant difference between phototypes for corneal punctate epithelial 
erosions (20/23; 69% vs 31/46; 54%, chi-squared test, p=0.3) and corneal vascularisation 
(11/23; 87% vs 11/46; 67%, chi-squared test, p=0.1).  
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Our study suggests for the first time that late ocular complications of SJS/TEN (visual 
loss, severe cicatrising conjunctivitis) could be more severe in phototypes V-VI, suggesting 
that dark phototypes could favor a pro-fibrotic process in the ocular surface. However, 
despite a higher risk of hypertrophic or keloid scars in dark phototypes, there are no 
published studies highlighting this complication in SJS/TEN. It has been shown that 
superficial skin injuries that primarily affect the epidermis might have different 
consequences on remodelling than deeper injuries involving the dermis.7 This might explain 
the scarcity of keloid scars in SJS/TEN as the disease primarily affects the epidermis. In 
contrast, in SJS/TEN, persistent conjunctival inflammation due to secondary reaction from 
ocular surface failure induced during the acute phase such as loss of goblet cells, accessory 
lacrimal glands, and secretory ductules of the main lacrimal glands and meibomian gland 
orifices, can induce progressively irreversible cicatricial changes.8 Our study has several 
limitations due to its retrospective design and the ophthalmological recruitment of patients. 
The time between the acute disease and the first consultation for scleral lens fitting may 
vary. The characteristics and management of the acute phase were unknown as well as the 
presence of skin sequelae (especially keloid scars). However, considering the rarity of 
SJS/TEN, we included a large number of patients and had a standardized ophthalmological 
examination.  
In conclusion, phototype should be considered as a factor associated for late severe 
ocular complications of SJS/TEN. 
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Figure 1: Late severe ocular complications of TEN in a phototype VI patient showing corneal 
scarring and neovascularisation (white arrow). (a) Severe cicatrising conjunctivitis as severe 
ocular complications of TEN in a phototype VI patient showing corneal neovascularisation 
(white arrow) and symblepharon (black arrow). (b) Late severe ocular complications of TEN 
in a light phototype patient showing corneal neovascularisation (white arrow) and corneal 
ulcer (black arrow). (c) Severe cicatrising conjunctivitis as severe ocular complications of TEN 
in a light phototype patient showing corneal neovascularisation (white arrow) and trichiasis 
(black arrow). (d) 
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